Your browser doesn't support javascript.
loading
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.
Grasso, Silvia; Chapelle, Jennifer; Salemme, Vincenzo; Aramu, Simona; Russo, Isabella; Vitale, Nicoletta; Verdun di Cantogno, Ludovica; Dallaglio, Katiuscia; Castellano, Isabella; Amici, Augusto; Centonze, Giorgia; Sharma, Nanaocha; Lunardi, Serena; Cabodi, Sara; Cavallo, Federica; Lamolinara, Alessia; Stramucci, Lorenzo; Moiso, Enrico; Provero, Paolo; Albini, Adriana; Sapino, Anna; Staaf, Johan; Di Fiore, Pier Paolo; Bertalot, Giovanni; Pece, Salvatore; Tosoni, Daniela; Confalonieri, Stefano; Iezzi, Manuela; Di Stefano, Paola; Turco, Emilia; Defilippi, Paola.
Affiliation
  • Grasso S; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Chapelle J; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Salemme V; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Aramu S; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Russo I; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Vitale N; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Verdun di Cantogno L; Department of Medical Sciences, University of Torino, 10126 Torino, Italy.
  • Dallaglio K; Research Infrastructure, IRCCS Arcispedale Santa Maria Nuova, 42100 Reggio Emilia, Italy.
  • Castellano I; Department of Medical Sciences, University of Torino, 10126 Torino, Italy.
  • Amici A; Department of Bioscience and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy.
  • Centonze G; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Sharma N; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Lunardi S; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Cabodi S; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Cavallo F; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Lamolinara A; Department of Medicine and Aging Science, Center of Excellence on Aging and Translational Medicine (CeSi-Met), G. D'Annunzio University, Chieti-Pescara, 66100 Chieti, Italy.
  • Stramucci L; Department of Medicine and Aging Science, Center of Excellence on Aging and Translational Medicine (CeSi-Met), G. D'Annunzio University, Chieti-Pescara, 66100 Chieti, Italy.
  • Moiso E; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Provero P; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
  • Albini A; Scientific and Technology Pole, IRCCS MultiMedica, 20100 Milan, Italy.
  • Sapino A; Department of Medical Sciences, University of Torino, 10126 Torino, Italy.
  • Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund 22100, Sweden.
  • Di Fiore PP; Molecular Medicine Program, European Institute of Oncology, 20100 Milan, Italy.
  • Bertalot G; IFOM, The FIRC Institute for Molecular Oncology Foundation, 20100 Milan, Italy.
  • Pece S; Department of Oncology and Hemato-oncology, University of Milan, 20100 Milan, Italy.
  • Tosoni D; Molecular Medicine Program, European Institute of Oncology, 20100 Milan, Italy.
  • Confalonieri S; Molecular Medicine Program, European Institute of Oncology, 20100 Milan, Italy.
  • Iezzi M; Department of Oncology and Hemato-oncology, University of Milan, 20100 Milan, Italy.
  • Di Stefano P; Molecular Medicine Program, European Institute of Oncology, 20100 Milan, Italy.
  • Turco E; Molecular Medicine Program, European Institute of Oncology, 20100 Milan, Italy.
  • Defilippi P; IFOM, The FIRC Institute for Molecular Oncology Foundation, 20100 Milan, Italy.
Nat Commun ; 8: 14797, 2017 03 16.
Article de En | MEDLINE | ID: mdl-28300085
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Récepteur ErbB-2 / Protéines G rac / Protéines adaptatrices du transport vésiculaire Type d'étude: Prognostic_studies Limites: Animals / Female / Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2017 Type de document: Article Pays d'affiliation: Italie
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Récepteur ErbB-2 / Protéines G rac / Protéines adaptatrices du transport vésiculaire Type d'étude: Prognostic_studies Limites: Animals / Female / Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2017 Type de document: Article Pays d'affiliation: Italie